Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System | MicrobiomeTrials← Back to trialsNCT02276547
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System
CompletedNAINTERVENTIONAL
Trial Details
Start: 2015-02-05Est. Completion: 2020-01-06
Enrollment target: 27 participants Locations- Cedars Sinai Medical Center, Los Angeles, California, United States
- Northwestern University, Chicago, Illinois, United States
- Henry Ford Health System, Detroit, Michigan, United States
- Washington University, St Louis, Missouri, United States
- Columbia University Medical Center, New York, New York, United States
- University of Washington Medical Center, Seattle, Washington, United States
- ZNA Middelheim, Antwerp, Belgium
- University of Alberta, Edmonton, Alberta, Canada
- St. Paul's Hospital, Vancouver, British Columbia, Canada
- London Health Sciences Centre, London, Ontario, Canada
Other microbiome trials you might be interested in
Healthy Volunteer
Background:
As people age, the cells in the pancreas that produce insulin begin to release less of this hormone, and le…
Baltimore, United StatesEst. completion Mar 31, 2027
Hemorrhagic StrokeAneurysm, IntracranialSaccular AneurysmFusiform AneurysmBrain Aneurysm
To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC Flow Modulation Device in the treatment of wide-n…
Phoenix, United StatesEst. completion Jul 2027
Chronic Subdural Hematoma
This is a Phase 1, open-label, single-center, dose-escalation study evaluating the safety and tolerability of intra-arte…
Multiple LocationsEst. completion Jan 1, 2029